Funder: National Institutes of Health

Due Dates: February 24, 2025 | June 20, 2025 | October 17, 2025 (New/Renewal/Resubmission/Revision) | May 7, 2025 | September 7, 2025 | January 7, 2026 (AIDS-related)

Funding Amounts: Up to $50,000 direct costs per year, for a maximum of 2 years (total up to $100,000 direct costs).

Summary: Supports small, well-defined cancer research projects that can be completed in a short period with limited resources, including pilot studies, data analysis, and technology/methodology development.

Key Information: Clinical trials are optional; foreign organizations are eligible; updated March 2025 to align with agency priorities—review full NOFO before applying.